Relationships between human genetic variation and drug responses are being documented at an accelerating rate, and have become some of the most promising avenues of research for understanding the molecular pathways of diseases and pharmaceuticals alike.
Drug-gene interactions are a cornerstone of personalized medicine. So it may seem surprising that, until October of 2013, a researcher interested in pharmacogenetics generally needed the help of a dedicated bioinformatician just to access the known background on a gene’s drug associations.
Obi and Malachi Griffith are particularly dedicated bioinformaticians, who specialize in applying data analytics to cancer research, and they figured they had the resources to improve this state of affairs.
Read the full, original story here: The Druggable Genome Is Now Googleable